BioSpace News Archive

BioMidwest

Remifentanil Hydrochloride for Injection CII Now Available from Fresenius Kabi

Fresenius Kabi Remifentanil for Injection is available as a lyophilized powder in three presentations: 1mg in a 3mL vial; 2 mg in a 5 mL vial and 5mg in a 10 mL vial.

January 26, 2018
·
5 min read
Business

Fluidigm to Report Q4 and Full Year 2017 Financial Results

A press release outlining the financial results will be publicly distributed before the call.

January 26, 2018
·
2 min read
Medtronic Launches IDE Study to Evaluate the Abre Venous Self-Expanding Stent System in Patients With Deep Venous Disease

The multi-center, single arm study intends to enroll 200 subjects with deep venous disease from up to 35 sites throughout the U.S. and Europe.

January 26, 2018
·
4 min read
Biotech Bay

Rigel Pharma, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(C)(4)

Rigel Pharma today announced that on January 15, 2018 and January 24, 2018 the Compensation Committee of Rigel’s Board of Directors approved the grants of inducement stock options to purchase an aggregate of 48,000 shares of common stock to three new employees.

January 26, 2018
·
2 min read
Business

CanniMed Therapeutics Inc. Announces 2017 Year End Financials Release Date

CanniMed Therapeutics Inc .announces that it plans to release its financial results for the year ended October 31, 2017 after close of markets on Monday, January 29, 2018.

January 26, 2018
·
2 min read
Policy

Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone in Duchenne Muscular Dystrophy

The CHMP concluded that an approval for Raxone in DMD, applied as a Type II variation of the existing marketing authorization, cannot be granted at the present time based on the current existing evidence

January 26, 2018
·
7 min read
Deals

resTORbio Scores $85M IPO

The offering is expected to close on January 30, 2018, subject to customary closing conditions.

January 26, 2018
·
2 min read
Biotech Bay

Anthera Receives Positive Nasdaq Listing Determination

Anthera’s continued listing on The Nasdaq Capital Market is subject to compli

January 26, 2018
·
1 min read
Policy

Kraig Biocraft Laboratories Expands Material Performance Testing Procedures

The Company identifies and implements plan to improve its recombinant spider silk.

January 26, 2018
·
3 min read
Genetown

Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

The total net proceeds of the offering are approximately $5.9 million after deducting the underwriting discounts and commissions payable by Histogenics.

January 26, 2018
·
2 min read